X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (23) 23
hematology (21) 21
humans (14) 14
middle aged (14) 14
aged (13) 13
female (13) 13
male (13) 13
ibrutinib (9) 9
survival (9) 9
waldenström macroglobulinaemia (9) 9
mutation (8) 8
waldenstrom macroglobulinemia - drug therapy (8) 8
2nd international workshop (7) 7
adult (7) 7
aged, 80 and over (7) 7
consensus panel recommendations (7) 7
myd88 (7) 7
therapy (7) 7
waldenstrom macroglobulinaemia (7) 7
patients (6) 6
chronic lymphocytic-leukemia (5) 5
cxcr4 mutations (5) 5
cxcr4 protein (5) 5
myd88 l265p (5) 5
retrospective studies (5) 5
waldenstrom macroglobulinemia - mortality (5) 5
cxcr4 (4) 4
diagnosis (4) 4
immunoglobulin m (4) 4
lymphoma (4) 4
oncology (4) 4
rituximab (4) 4
somatic mutation (4) 4
survival analysis (4) 4
treatment outcome (4) 4
abridged index medicus (3) 3
activation (3) 3
biomarkers (3) 3
immunoglobulin m - blood (3) 3
l265p (3) 3
macroglobulinemia (3) 3
monoclonal gammopathy (3) 3
myd88 protein (3) 3
online only (3) 3
online only articles (3) 3
open-label (3) 3
pyrazoles - adverse effects (3) 3
pyrimidines - adverse effects (3) 3
risk factors (3) 3
transformation (3) 3
waldenstrom macroglobulinemia - genetics (3) 3
waldenstrom macroglobulinemia - therapy (3) 3
amyloidosis (2) 2
antineoplastic agents - adverse effects (2) 2
bendamustine (2) 2
care and treatment (2) 2
confidence intervals (2) 2
dexamethasone (2) 2
end results database (2) 2
epidemiology (2) 2
final analysis (2) 2
genomic landscape (2) 2
haemodialysis (2) 2
igm myeloma (2) 2
incidence (2) 2
inhibition (2) 2
international workshop (2) 2
kaplan-meier estimate (2) 2
l265p somatic mutation (2) 2
lymphoid neoplasia (2) 2
lymphomas (2) 2
multicenter (2) 2
multiple myeloma (2) 2
myeloid differentiation factor 88 - genetics (2) 2
naive patients (2) 2
outcomes (2) 2
overall survival (2) 2
patient outcomes (2) 2
pyrazoles - administration & dosage (2) 2
pyrimidines - administration & dosage (2) 2
receptors, cxcr4 - genetics (2) 2
renal medicine (2) 2
response (2) 2
rituximab - administration & dosage (2) 2
tyrosine kinase (2) 2
waldenstrom macroglobulinemia (2) 2
waldenstrom macroglobulinemia - blood (2) 2
waldenstrom macroglobulinemia - complications (2) 2
waldenstrom macroglobulinemia - epidemiology (2) 2
waldenstrom macroglobulinemia - pathology (2) 2
abdominal fat - metabolism (1) 1
abdominal fat; adult; aged; aging; animals; body weight; cardiovascular diseases; diet; female; humans; male; mice; mice, inbred c57bl; middle aged; neoplasms; neurogenesis; pilot projects; psychomotor performance; regeneration; saccharomyces cerevisiae; young adult; cognition; fasting; longevity (1) 1
abstracts (1) 1
adult hippocampal neurogenesis (1) 1
age factors (1) 1
age of onset (1) 1
aging (1) 1
alleles (1) 1
animals (1) 1
antimitotic agents (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American journal of hematology, ISSN 0361-8609, 2018, Volume 93, Issue 8, pp. E201 - E202
Journal Article
BRITISH JOURNAL OF HAEMATOLOGY, ISSN 0007-1048, 02/2018, Volume 180, Issue 3, pp. 374 - 380
MYD88 mutations are present in 95% of Waldenstrom Macroglobulinaemia (WM) patients, and support diagnostic discrimination from other IgM-secreting B-cell... 
L265P SOMATIC MUTATION | IGM MULTIPLE-MYELOMA | VARIANTS | overall survival | IBRUTINIB | CXCR4 | transformation | MARGINAL ZONE LYMPHOMA | HEMATOLOGY | IgM myeloma | Waldenstrom Macroglobulinaemia | MYD88
Journal Article
Journal Article
Open forum infectious diseases, ISSN 2328-8957, 11/2018, Volume 5, Issue suppl_1, pp. S338 - S339
Journal Article
Haematologica, ISSN 0390-6078, 09/2018, Volume 103, Issue 10, pp. e466 - e468
Journal Article
British journal of haematology, ISSN 0007-1048, 2019, Volume 187, Issue 3, pp. 356 - 363
Summary Ibrutinib is associated with response rate of 90% and median progression‐free survival (PFS) in excess of 5 years in Waldenström macroglobulinaemia... 
ibrutinib | CXCR4 | Waldenström macroglobulinaemia | response | survival | Medicine, Experimental | Medical research | Confidence intervals | Therapy | Mutation | Impact response | Survival | CXCR4 protein
Journal Article